In a significant move to advance Qatar’s role in the field of precision medicine, the Qatar Precision Health Institute (QPHI), part of Qatar Foundation (QF), unveiled a groundbreaking collection of 25,000 new genomic data points at a recent event held at Qatar Foundation’s headquarters. This initiative, attended by prominent figures from Qatar’s healthcare and research sectors, aims to catalyze advancements in precision health and foster new opportunities for collaborative research.
The event drew an esteemed audience, including Sheikh Dr. Mohammed Al-Thani, Director of the Non-Communicable Diseases Prevention Program at the Ministry of Public Health – Qatar, Prof. Khalid A. Fakhro, Chief of Research and Chair of the Precision Medicine Program at Sidra Medicine, and other influential stakeholders from Qatar’s biomedical and research institutions.
Dr. Said Ismail, Acting President and Chief Scientific Operations Officer at QPHI, emphasized the importance of this genomic data release, describing it as “a milestone that cements Qatar’s leadership in precision medicine.” He highlighted that this expansive data repository serves as a foundation for groundbreaking research, positioning Qatar as a pivotal hub for genomics and translational health studies.
During his presentation, Dr. Chadi Saad, QPHI Lead Bioinformatician, introduced the 25,000 Genome Release, which supports advanced research across critical health areas like cancer genetics, cardiovascular conditions, and mental health. He noted that enhanced data analysis tools are now helping to reduce the cost and time needed for such research, opening doors to more cost-effective and impactful healthcare solutions.
Dr. Eleni Fthenou, Scientist at QPHI, introduced an updated data catalog designed to streamline research access. She highlighted that the new platform enables researchers to explore genetic data more efficiently, fostering synergies and equipping the academic community with valuable tools to innovate and develop targeted treatments. “We empower researchers to build solutions and meet community needs through this accessible platform,” she remarked.
Additionally, Sneha P. Chandran, Warehouse Specialist at QPHI, showcased a new tool enabling researchers to conduct advanced filtering and criteria-based analysis within QPHI’s vast genomic data repository. She noted, “Researchers now have the flexibility to build specific cohorts and conduct in-depth analyses tailored to their projects.”
Dr. Hamdi Mbarek, Director of Research and Partnerships at QPHI, concluded the event by announcing the second phase of the Qatar Precision Health Research Consortium (QPHRC). This initiative focuses on genomics research in cancer, cardiovascular diseases, reproductive health, and mental health, as well as emerging areas like AI in genomics. Dr. Mbarek highlighted the consortium’s mission to unite researchers across institutions to tackle Qatar’s and the region’s most pressing health challenges, including local capacity-building for doctoral candidates.
“The consortium aims to foster multi-institutional collaboration, driving teams to address urgent health challenges with cutting-edge genomic data. This effort will ultimately yield patient care breakthroughs,” Dr. Mbarek shared.
He also expressed gratitude to various stakeholders—including MoPH, Hamad Medical Corporation, Sidra Medicine, Qatar Science and Technology Park, Qatar University, Weill Cornell Medicine-Qatar, and other prominent research entities—whose support has been essential to QPHI’s mission.
QPHI’s initiatives reflect its dedication to transforming healthcare through precision medicine. As the institute collaborates with local and international partners, it continues to shape the future of healthcare, pushing forward advancements that will benefit both Qatar and the global precision medicine community.
